期刊文献+

难溶性中药纳米混悬剂的体内外行为研究进展 被引量:16

Research progress on in vitro and in vivo behaviors of poorly soluble Chinese materia medica nanosuspension
原文传递
导出
摘要 纳米混悬剂(也可称为纳米晶体混悬剂或纳米晶)可通过减小粒径,增加比表面积,显著增加难溶性药物的饱和溶解度和溶出,改善其生物利用度,解决难溶性中药有效成分和有效部位的递送难题。该文在简要概括纳米混悬剂的制备方法的基础上,主要对难溶性中药纳米混悬剂的体内外行为研究进行综述,并对研究中存在的问题进行分析探讨,以期为难溶性中药纳米混悬给药系统的进一步研究提供借鉴和思考,促进纳米混悬技术在中药制剂中的发展和完善。 Nanosuspension(also called nanocrystal suspension or nanocrystal) could significantly enhance the saturated solubility and dissolution of insoluble drugs, and improve their bioavailability by reducing particle size and increasing the specific surface, which could then solve the delivery problems of the poorly soluble active ingredients and effective parts of Chinese materia medica(CMM). Based on the brief summaries of nanosuspension preparation methods, this paper would mainly review the in vitro and in vivo behaviors of poorly soluble CMM nanosuspension, discuss and analyze its problems, so as to provide reference and thinking for the further study of nanosuspension drug delivery system of poorly soluble CMM and promote the development and perfection of nanosuspension technology in CMM.
作者 申宝德 沈成英 徐玲霞 朱卫丰 袁海龙 SHEN Bao-de;SHEN Cheng-ying;XU Ling-xia;ZHU Wei-feng;YUAN Hai-long(Key Laboratory of Modern Preparation of Traditional Chinese Medicine (TCM),Ministry of Education,Jiangxi University of TCM ,Nanchang 330004,China;Department of Pharmacy,Air Force General Hospital,PLA ,Beijing 100142,China)
出处 《中国中药杂志》 CAS CSCD 北大核心 2018年第19期3828-3833,共6页 China Journal of Chinese Materia Medica
基金 国家自然科学基金项目(81803741,81873092,81573697) 军队后勤科研重点项目(BKJ16J025)
关键词 中药 纳米混悬剂 制备方法 体内外行为 研究进展 Chinese materia medica nanosuspension preparation method in vitro/vivo behavior research progress
  • 相关文献

参考文献10

二级参考文献102

  • 1朱建芬,吴祥根.纳米混悬剂的制备方法及在药剂学中应用的研究进展[J].中国医药工业杂志,2006,37(3):196-200. 被引量:38
  • 2王懿睿,杜光.难溶性药物纳米混悬剂制备工艺及其应用[J].中国医院药学杂志,2007,27(11):1573-1576. 被引量:16
  • 3Basniwal R K,Buttar H S,Jain V K,et al. Curcuminnanoparticles: preparation, characterization, andantimicrobial study [J]. J Agric Food Chem, 2011, 59(5):2056-2061.
  • 4Shin M S, Lee Y, Kim H. Method for preparingnanoparticles comprising vitamin K and poly-isopropyl-butyl methacrylate-acrylic acid copolymer withsupercritical fluid using molecular association theory: USPatent, 20080152715 [P]. 2008-06-26.
  • 5Salazar J, Heinzerling O, Muller R H, et al. Processoptimization of a novel production method fornanosuspensions using design of experiments (DoE) [J].IntJPharm, 2011,420(2): 395-403.
  • 6Kipp J E, Doty M J, Rebbeck C L, et al. Compositions ofand method for preparing stable particles in a frozenaqueous matrix: US Patent, 7112340 [P]. 2006-09-26.
  • 7Muller R H, Gohla S, Keck C M. State of the art ofnanocrystals-special features, production, nanotoxicologyaspects and intracellular delivery [J]. Eur J PharmBiopharm, 2011, 78(1): 1-9.
  • 8Lindfors L, Skantze P, Skantze U, et al. Amorphous drugnanosuspensions [J]. Langmuir, 2006,22(3): 906-916.
  • 9Miiller R H, Peters K. Nanosuspensions for theformulation of poorly soluble drugs [J]. Int J Pharm,1998, 160(2): 229-237.
  • 10Yue P F, Li G, Dan J X,et al. Study on formability ofsolid nanosuspensions during solidification II: Novelroles of freezing stress and cryoprotectant property [J]. IntJ Pharm, 2014, 475(1): 35-48.

共引文献94

同被引文献224

引证文献16

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部